NEW YORK (GenomeWeb) – S2 Genomics announced today that it has received a $280,000 Phase 1 Small Business Technology Transfer grant from the National Institutes of Health's Human Genome Research Institute.

S2 will use the funds to develop its Singulator system for automated preparation of single cells. The Singulator system includes single-use sample cartridges and reagents that allow researchers to quickly isolate cells or nuclei with minimal impact on the cellular transcriptome, the firm added.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.